- Home
- CGTX vs IRIX Comparison
CGTX vs IRIX Comparison
Compare CGTX & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGTX
- IRIX
- Stock Information
- Founded
- CGTX 2007
- IRIX 1989
- Country
- CGTX United States
- IRIX United States
- Employees
- CGTX N/A
- IRIX N/A
- Industry
- CGTX Biotechnology: Pharmaceutical Preparations
- IRIX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CGTX Health Care
- IRIX Health Care
- Exchange
- CGTX Nasdaq
- IRIX Nasdaq
- Market Cap
- CGTX 20.5M
- IRIX 16.5M
- IPO Year
- CGTX 2021
- IRIX 1996
- Fundamental
- Price
- CGTX $0.32
- IRIX $1.00
- Analyst Decision
- CGTX Strong Buy
- IRIX
- Analyst Count
- CGTX 5
- IRIX 0
- Target Price
- CGTX $5.63
- IRIX N/A
- AVG Volume (30 Days)
- CGTX 1.7M
- IRIX 80.2K
- Earning Date
- CGTX 05-07-2025
- IRIX 05-13-2025
- Dividend Yield
- CGTX N/A
- IRIX N/A
- EPS Growth
- CGTX N/A
- IRIX N/A
- EPS
- CGTX N/A
- IRIX N/A
- Revenue
- CGTX N/A
- IRIX $48,804,000.00
- Revenue This Year
- CGTX N/A
- IRIX $9.61
- Revenue Next Year
- CGTX N/A
- IRIX N/A
- P/E Ratio
- CGTX N/A
- IRIX N/A
- Revenue Growth
- CGTX N/A
- IRIX N/A
- 52 Week Low
- CGTX $0.22
- IRIX $0.78
- 52 Week High
- CGTX $2.54
- IRIX $2.56
- Technical
- Relative Strength Index (RSI)
- CGTX 47.90
- IRIX 44.95
- Support Level
- CGTX $0.24
- IRIX $0.94
- Resistance Level
- CGTX $0.34
- IRIX $1.09
- Average True Range (ATR)
- CGTX 0.03
- IRIX 0.06
- MACD
- CGTX -0.00
- IRIX -0.01
- Stochastic Oscillator
- CGTX 68.84
- IRIX 30.77
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.
About IRIX IRIDEX Corporation
IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.